Live Breaking News & Updates on Bend Points

Stay updated with breaking news from Bend points. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Finding the balance between access to, security of data in a borderless world

The global, borderless nature of business introduces risk as there are multiple applications, systems and end points that represent potential vulnerabilities, says Ryan Boyes, GRC officer at Galix. ....

Bryan Boyes , Compliance Officer , Yan Boyes , Bend Points , Physical Security ,

RNA Interference With Zilebesiran for Mild to Moderate Hypertension

This phase 2 randomized trial examines the antihypertensive efficacy and safety of different zilebesiran dosing regimens. ....

United States , United Kingdom , University Of Chicago , Eteläuomen Läi , Eli Lilly , Vifor Pharma , Pharmagenesis Cardiff , Georgel Bakris , Boehringer Ingelheim , American Heart Association Comprehensive Hypertension Center , Novo Nordisk , International Conference On Harmonization , Department Of Medicine , American Heart Association Scientific Sessions , Study Group , Group Information , University Of Chicago Medicine , Recor Medical Inc , Alnylam Pharmaceuticals , Ablative Solutions Inc , Good Clinical Practice , International Conference , Renal Disease , Medical Dictionary , Regulatory Activities , End Point ,

Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure: The ARIES-HM3 Randomized Clinical Trial | Cardiology | JAMA

This randomized clinical trial examines the safety of the exclusion of aspirin as part of an antithrombotic regimen including a vitamin K antagonist with a full ....

Nordrhein Westfalen , United States , United Kingdom , Czech Republic , Mandeepr Mehra , Bristol Myers Squibb , Abbott Inc , University Of Michigan , Vascular Center , Almac Group , Us Bureau Of Labor Statistics , Group Information , Heartware Ventricular Assist Device , Antiplatelet Removal , Hemocompatibility Events With , North America , End Point , Secondary End Point , Bend Points , Labor Statistics , Level Questionnaire , Aspirin Effect , Size Assessment , Survival Free , Nonsurgical Bleeding Events , Hospital Heart ,

Aldosterone Synthase Inhibition With Lorundrostat for Uncontrolled Hypertension

This randomized clinical trial assesses the effect of 5 dosages of lorundrostat treatment vs placebo on 8-week systolic blood pressure change among adults with ....

United States , Catalys Pacific , Stevene Nissen , Novo Nordisk , Group Information , Gordy Health , Bristol Myers Squibb , Lucidact Health , Clinical Research , Boehringer Ingelheim , Tanabe Pharmaceuticals , American Heart Association Hypertension Scientific Sessions , Institute Inc , Amsterdam Pharmaceuticals , Cleveland Clinic Coordinating Center , Between July , Patients With Uncontrolled Hypertension , Bend Points , Size Calculation , African American , End Point , Exploratory End Points , Biomarker End Points , Mitsubishi Tanabe Pharmaceuticals , Cleveland Clinic , Drs Laffin ,

FDA Approval Sought for Crovalimab for Paroxysmal Nocturnal Hemoglobinuria

The FDA has accepted a biologics license application seeking the approval of crovalimab for use in patients with paroxysmal nocturnal hemoglobinuria. ....

Levi Garraway , Global Product Development , Key Objectives , Eligibility Criteria , Bend Points , Hematologic Oncology ,